Özsan GH - Search Results

1

Nilotinib Does Not Alter the Secretory Functions of Carotid Artery Endothelial Cells in a Prothrombotic or Antithrombotic Fashion.

Katgı A, Sevindik ÖG, Gökbulut AA, Özsan GH, Yüksel F, Solmaz ŞM, Alacacıoğlu İ, Özcan MA, Demirkan F, Baran Y, Pişkin Ö. Katgı A, et al. Among authors: ozsan gh. Clin Appl Thromb Hemost. 2015 Oct;21(7):678-83. doi: 10.1177/1076029614550817. Epub 2014 Sep 18. Clin Appl Thromb Hemost. 2015. PMID: 25239946 Free article.

2

Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Behçet's disease.

Akarsu M, Demirkan F, Ozsan GH, Onen F, Yüksel F, Ozkan S, Undar B. Akarsu M, et al. Among authors: ozsan gh. Am J Hematol. 2001 Dec;68(4):225-30. doi: 10.1002/ajh.1186. Am J Hematol. 2001. PMID: 11754410 Free article.

3

Effect of granulocyte-colony-stimulating factor on serum lactate dehydrogenase levels and isoenzymes in a rabbit model.

Menekay S, Ozsan GH, Demirkan F, Ozbek D, Ozcan MA, Fadíloğlu M, Undar B. Menekay S, et al. Among authors: ozsan gh. Acta Haematol. 2002;107(1):18-22. doi: 10.1159/000046624. Acta Haematol. 2002. PMID: 11818667

4

Hemophagocytic syndrome associated with inappropiate secretion of antidiuretic hormone in lymphoma and acute myeloblastic leukemia: report of two cases.

Demirkan F, Vural F, Ozsan GH, Ozcan MA, Ozkal S, Undar B. Demirkan F, et al. Among authors: ozsan gh. Leuk Lymphoma. 2001 Nov-Dec;42(6):1401-4. doi: 10.3109/10428190109097769. Leuk Lymphoma. 2001. PMID: 11911425

5

EBV-associated nasal-type T/natural killer cell lymphoma presenting with polyserositis and rhabdomyolysis.

Vural F, Demirkan F, Ozsan GH, Kargi A, Cabuk M, Ozcan MA, Sayan M, Ozkal S, Cehreli C, Undar B. Vural F, et al. Among authors: ozsan gh. Leuk Lymphoma. 2002 Sep;43(9):1859-63. doi: 10.1080/1042819021000006376. Leuk Lymphoma. 2002. PMID: 12685845

6

Plasma levels of free tissue factor pathway inhibitor in patients with various thyroid disorders.

Ozcan MA, Cömlekçi A, Demirkan F, Yüksel F, Sari I, Demir T, Ozsan GH, Orük G, Yeşil S, Undar B. Ozcan MA, et al. Among authors: ozsan gh. Thromb Res. 2003 Jun 1;110(4):243-7. doi: 10.1016/s0049-3848(03)00408-0. Thromb Res. 2003. PMID: 14512089

7

Gingival involvement in a patient with CD56+ chronic myelomonocytic leukemia.

Vural F, Ozcan MA, Ozsan GH, Demirkan F, Piskin O, Ates H, Kargi A, Undar B. Vural F, et al. Among authors: ozsan gh. Leuk Lymphoma. 2004 Feb;45(2):415-8. doi: 10.1080/1042819031000139639. Leuk Lymphoma. 2004. PMID: 15101735

8

Cyclo-oxygenase 2 inhibitor, nabumetone, inhibits proliferation in chronic myeloid leukemia cell lines.

Vural F, Ozcan MA, Ozsan GH, Ateş H, Demirkan F, Pişkin O, Undar B. Vural F, et al. Among authors: ozsan gh. Leuk Lymphoma. 2005 May;46(5):753-6. doi: 10.1080/10428190400027860. Leuk Lymphoma. 2005. PMID: 16019514

9

Bilateral primary orbital non-Hodgkin's lymphoma in a patient with scleroderma: a case report.

Alacacioglu I, Ozcan MA, Kocak N, Demiral A, Piskin O, Demirkan F, Ozsan GH, Saatci AO, Undar B. Alacacioglu I, et al. Among authors: ozsan gh. Leuk Lymphoma. 2005 Aug;46(8):1239-42. doi: 10.1080/10428190500097748. Leuk Lymphoma. 2005. PMID: 16085569

10

Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.

Akar S, Ozcan MA, Ateş H, Gürler O, Alacacioglu I, Ozsan GH, Akkoç N, Ozkan S, Demirkan F, Onen F. Akar S, et al. Among authors: ozsan gh. Clin Appl Thromb Hemost. 2006 Oct;12(4):451-7. doi: 10.1177/1076029606293430. Clin Appl Thromb Hemost. 2006. PMID: 17000890 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters